So far more than one crore 28 lakh people have been infected with the novel coronavirus and nearly 5 lakh 55 thousand people have died due to the disease Covid-19 caused by this virus.
After a nearly seven-month-long outbreak of the virus, Russia has claimed that 'their scientists have made the first vaccine of the coronavirus'.
According to Russian news agency Sputnik, Vadim Tarasov, director of the Institute for Translational Medicine and Biotechnology, said that "the clinical trial of the world's first corona vaccine has been completed."
He told that 'the Moscow-based government medical university Sechenof conducted these trials and found that this vaccine is safe on humans. One group of people who have been tried the vaccine will be discharged from the hospital on July 15 and another group on July 20.
On 18 June, the university began clinical trials of the vaccine produced by Russia's Gameli Institute of Epidemiology and Microbiology.
According to Alexander Lukashev, another senior officer at Sechinoff University, 'The purpose of this phase of the vaccine trial was to ensure that the vaccine is safe for humans or not. The trial has been completed. We have found that this vaccine is safe.
Lukashev has said that the strategy is being set for what preparations are to be made for the comprehensive production of the vaccine.
Vadim Tarasov said, "During the pandemic period, Sechenof University not only functioned as an educational institution but also as a scientific and technological research center, capable of being involved in the manufacture of important and complex products such as medicines. is."
So far, more than 7 million people in the whole world have been completely cured after being infected with the coronavirus.
Because of this, scientists and other healthcare-related institutions around the world are making all efforts to complete the production and development of the Covid-19 vaccine at the earliest.
Gilead Sciences, currently a researcher at Oxford University and the American biotech company Moderna - is currently at the forefront of developing the vaccine for Covid-19. The initial results of the vaccine at Oxford University in Britain have also been encouraging.
At the same time, clinical trials of vaccines made in India are also going on.
However, Gilead Sciences previously stated that an analysis showed that 'their anti-viral drug remadecivir helped reduce the risk of death in critically ill Covid-19 patients', but the company cautioned It also said that 'rigorous clinical trials need to be done to confirm the benefits of Remedisvir'.
The administration is on high alert in view of Cyclone Ditwah. Following the forecast of heavy ra
The Indian ODI team will depart for Australia from Delhi on October 15th in two groups, and the f
Next hearing in the Allu Arjun case on January 3, Pawan Kalyan said the police action was correct
Important comments of Andhra Pradesh Deputy Chief Minister Pawan Kalyan have come to the fore in
Russia is preparing for a major attack on Ukraine. The Russian army soon wants to capture the cap
The IT system of insurance aggregator Company Policy Bazaar has been hacked. PB Fintech, the pare
Today is Super Saturday in IPL. The first match of the day will be played between Mumbai Indians
Imran Khan and Army have very close ties: Minister Fawad Chaudhry
Pakistan's Information and Broadcasting Minister Fawad Chaudhry has said that he wants to say wit
Chandrayaan-3: Spacecraft attached to rocket for launch, to be launched between July 13 and 19
The Indian Space Research Organization (ISRO) on Wednesday attached the encapsulated assembly con
Smartphones deteriorating due to use of sanitizer during Corona era, know how to protect?
Sanitizer has been in use around the world for many years, but the coronavirus epidemic has taken
The hijab controversy has once again started heating up in Karnataka. Some students of Mangaluru
